Gliomatosis cerebri other imaging findings: Difference between revisions
| Line 13: | Line 13: | ||
*Eelevated [[choline]]/[[creatine]] ratio | *Eelevated [[choline]]/[[creatine]] ratio | ||
*Elevated [[choline]]/[[N-Acetylaspartic acid|NAA]] ratio | *Elevated [[choline]]/[[N-Acetylaspartic acid|NAA]] ratio | ||
*Marked elevation of [[myoinositol]] | *Marked elevation of [[myo-inositol|myoinositol]] | ||
===3. PET=== | ===3. PET=== | ||
Revision as of 01:28, 2 October 2015
|
Gliomatosis cerebri Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gliomatosis cerebri other imaging findings On the Web |
|
American Roentgen Ray Society Images of Gliomatosis cerebri other imaging findings |
|
Risk calculators and risk factors for Gliomatosis cerebri other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Other imaging studies for high-grade gliomas include MR spectroscopy, MR perfusion, PET scan (markedly decreased accumulation of [18F]-fluorodeoxyglucose), and bone scan (metastasis to bones).[1]
Other Imaging Findings
Other imaging studies for gliomatosis cerebri include MR spectroscopy, MR perfusion, PET scan (markedly decreased accumulation of [18F]-fluorodeoxyglucose), and bone scan (metastasis to bones).[1]
MR Spectroscopy
Other imaging studies for gliomatosis cerebri include MR spectroscopy. Common findings are described below:
- Eelevated choline/creatine ratio
- Elevated choline/NAA ratio
- Marked elevation of myoinositol
3. PET
Other imaging studies for high-grade gliomas include PET scan, which demonstrates markedly decreased accumulation of [18F]-fluorodeoxyglucose (glucose hypometabolism).[1]
4. Bone Scan
Bone scan may be performed to detect metastases of gliomatosis cerebri to bones.
References
- ↑ 1.0 1.1 1.2 Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri